Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination

JAMA Oncol. 2021 Sep 1;7(9):1395-1397. doi: 10.1001/jamaoncol.2021.3127.

Authors

Kristin A Robinson¹, Santo Maimone¹, Denise A Gococo-Benore², Zhuo Li³, Pooja P Advani⁴, Saranya Chumsri⁴

Affiliations

¹ Department of Radiology, Mayo Clinic, Jacksonville, Florida.
² Department of Internal Medicine, Mayo Clinic, Jacksonville, Florida.
³ Department of Quantitative Health Science, Mayo Clinic, Jacksonville, Florida.
⁴ Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida.

Abstract

This case series examines the incidence, timing, and characteristics of mammographic axillary adenopathy following COVID-19 vaccination.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Aged, 80 and over
Axilla / diagnostic imaging*
Breast / diagnostic imaging*
Breast Neoplasms / diagnosis
COVID-19 / prevention & control
COVID-19 Vaccines / adverse effects*
Female
Humans
Incidence
Lymphadenopathy / diagnostic imaging
Lymphadenopathy / etiology*
Mammography
Middle Aged
SARS-CoV-2 / immunology
Ultrasonography

Substances

COVID-19 Vaccines